Both in Pharmaceuticals
Zentalis Pharmaceuticals vs AN2 Therapeutics
Over the past year ZNTL returned +33.3% and ANTX returned +272.8%; their daily moves had a correlation of 0.10.
ZNTL +33.3% ANTX +272.8%Growth of $1, one year, split-adjusted
| Metric | ZNTL | ANTX |
|---|---|---|
| Price | $1.76 | $4.25 |
| Market cap | $166.6M | $160.4M |
| Today | −1.12% | +1.67% |
| 1 month | −34.1% | −16.2% |
| 6 months | −57.9% | −8.6% |
| Year to date | +30.4% | +272.8% |
| 1 year | +22.2% | +269.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $174.6M | $78.4M |
| Dividend yield | — | — |
| Volatility (60d) | 71.0% | 75.2% |
| Short % of float | 9.1% | 10.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).